Letter from the editor

Abstract

This issue of Human Vaccines & Immunotherapeutics starts with the Coronavirus section featuring research studies on the yeastexpressed vaccine candidate SARS_CoV-2 RBD219-N1C1 (Pollet, p 2356), trends in bibliometric data on Covid-19 (Ahmad, p 2367), vaccine (mis)information on TikTok (Basch, p 2373), vaccine acceptance among pregnant women in China (Tao, p 2378), impact of disease experiences on willingness to receive a vaccine among Turkish pediatricians (Gönüllü, p 2389), intentions to receive a vaccine among Greek healthcare workers (HCWs) (Raftopoulos, p 2397) and Chinese adults (Liu, p 2405), vaccine perceptions and hesitancy in Jordan (Abu Farha, p 2415), media vaccine coverage in Nigeria (Asogwa, p 2421), impact of the pandemic on the coverage of other vaccines in Ethiopia (Miretu, p 2427), three commentaries on SARS-CoV-2 phylodynamics (Cardona-Ospina, p 2437), the mRNA platform for Covid-19 vaccines (Mussa, p 2445), and the role of BCG vaccination in fighting the pandemic (Kelleni, p 2448), and a Letter to the Editor on the potential impact of population-wide BCG vaccination on mortality from SARS-CoV-2 (Marín-Hernández, p 2451). Eighteen articles on Licensed Vaccines include reviews of the progress toward tuberculosis eradication (Cho, p 2454) and immune responses to Yellow Fever vaccination (Bovay, p 2471), an assessment of zoster vaccine uptake and completion in US (Patterson, p 2482), an estimate of the reproductive number for varicella in South Korea (Lee, p 2488), epidemiology of varicella in Japanese children (Yasui, p 2494), a report on the development of microneedle-delivered dried formulation of the combined measles and rubella vaccine (Wan, p 2501), analysis of measles seroprevalence among South Korean HCWs (Han, p 2517), evaluation of seroprevalence and persistence following measles vaccination and infection in Saudi Arabia (Mahallawi, p 2522), characterization of T-cell (Zhao, p 2530) and B-cell (Zhao, p 2538) responses following rabies vaccination, two safety and immunogenicity trials of post-exposure rabies vaccination (Zhang, p 2547, and Haradanahalli, p 2554), profiling of mucosal immunity following the bivalent oral polio vaccine (Zhao, p 2560), safety surveillance study of Sabin-strain inactivated polio vaccine in China (Kang, p 2568), a commentary on polio vaccine misinformation on social media (Ittefaq, p 2575), a case-series analysis of acute disseminated encephalomyelitis following routine childhood vaccinations (Martin, p 2578), immunogenicity study of cholera vaccination in children with inflammatory bowel disease (Dembiński, p 2586), and a Letter to the Editor on vaccination of subjects with hereditary fructose intolerance (Saborido-Fiaño, p 2593). The Immunotherapy segment presents strategies to sensitize cancer cells to immunotherapy (George, p 2595), a review of immunotherapy of myelodysplastic syndrome (Linder, p 2602), a novel Listeria-based therapeutic vaccine for cervical cancer (Galicia-Carmona, p 2617), and a case report on pembrolizumab for choroidal metastases of NSCLC (Li, p 2626). The Acceptance section investigates potential association between vaccination and undernutrition in Nigerian children (Sato, p 2630), a vaccine hesitancy scale for use in adults (Akel, p 2639), and vaccine attitudes among university students in Cyprus (Guzoglu, p 2647) and among Swiss parents (Olarewajuo, p 2652). Five Pneumococcal articles introduce an assessment of a PPSV vaccination campaign in Japanese elderly (Kobayashi, p 2661), a commentary on the development of a novel 10-valent PCV (Alderson, p 2670), a trial of sequential administration of PCV-13 and PPSV-23 in older adults (Buchwald, p 2678), safety and immunogenicity study of a novel PCV-7 vaccine (Essink, p 2691), and analysis of vaccine coverage in Danish HIV subjects (Larsen, p 2700). The section on Influenza presents a review of determinants of vaccine immunogenicity (Wen, p 2706), a survey of vaccine coverage in Belgian HCWs (Samyn, p 2719), and a commentary on the vaccination of pregnant women (Maltezou, p 2723). Three studies on HPV highlight vaccine knowledge and attitudes among dentists (Xu, p 2728) and college students (Yin, p 2736) in China, and preclinical development of a new adjuvant for a VLP vaccine (Valencia, p 2748). The Hepatitis segment includes two HBV vaccine immune persistence studies of three doses of HBV vaccine in primary non-responders (Zhu, p 2762) and in Turkish children (Bayhan, p 2768), and a Letter to the Editor on the validation of seroconversion in HBV vaccinees (Zeng, p 2773) with a Response Letter (Zheng, p 2775). Finally, we are happy to introduce a cost-effectiveness study of a 4-valent Meningococcal conjugate vaccine in teenagers (Watle, p 2777), Moroccan National Immunization Technical Advisory Group as an important Public Health body in the region (Jroundi, p 2788), a preclinical trial of a Novel Vaccine against dengue virus (Jearanaiwitayakul, p 2793), a commentary on a novel adjuvant Technology for Covid-19 vaccination based on β-Glucans (Ikewaki, p 2808), and a Letter on a Rotavirus outbreak in China (Lu, p2814). Our monthly News, Policy and Profiles (NP&P) track offers a selection of the latest news in the field of vaccines and immunotherapeutics. In this section we also regularly publish opinion pieces on timely, interesting and controversial topics related to vaccines and immunotherapeutics, profiles of companies and organizations, as well as portraits of distinguished scientists in our field. Please contact Acquisitions Editor Adam Weiss (adam. [email protected]) with your ideas for commentaries, opinion pieces, profiles and portraits. Your suggestions for and contributions to our N&P&P track are always welcome!